[Skip to Content]
[Skip to Content Landing]
Views 356
Citations 0
Comment & Response
March 2016

Toxin Immunoassays and Clostridium difficile Infection

Author Affiliations
  • 1Department of Clinical Microbiology, Trinity College Dublin, Clinical Microbiology, Dublin, DO8 RX0X, Ireland
  • 2Department of Clinical Microbiology, St James's Hospital
  • 3Department of Clinical Microbiology, Trinity College Dublin, Trinity College Dublin, St James's Hospital, Dublin Dublin 8, Ireland
JAMA Intern Med. 2016;176(3):413-414. doi:10.1001/jamainternmed.2015.8536

To the Editor We read with interest the recent article in JAMA Internal Medicine by Polage et al,1 who report on the outcomes of Clostridium difficile infection (CDI), using a laboratory diagnostic strategy of either combined toxin enzyme immunoassay and polymerase chain reaction (PCR) assay results or on the basis of the PCR assay result alone. Their conclusion was that patients with only a positive PCR (PCR+) result had outcomes similar to patients without C difficile infection and that exclusive reliance on molecular tests for CDI diagnosis is likely to result in overdiagnosis and overtreatment.

First Page Preview View Large
First page PDF preview
First page PDF preview